XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.1
10. Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2020
Aug. 31, 2019
Mar. 31, 2022
Mar. 31, 2021
Sep. 30, 2021
Dec. 31, 2021
Sep. 04, 2020
Class of Warrant or Right [Line Items]              
Preferred stock, authorized (in shares)     10,000,000     10,000,000  
Preferred stock, per value (in usd per share)     $ 0.001     $ 0.001  
Preferred stock, outstanding (in shares)     0     0  
Common stock, authorized (in shares)     240,000,000 240,000,000   240,000,000  
Common stock voting right     Each share of common stock is entitled to one voting right        
Proceeds from exercise of warrants     $ 5,868,000      
September 2020 Warrants [Member]              
Class of Warrant or Right [Line Items]              
Number of shares of common stock issued 6,648,750            
Warrants exercisable as of June 30, 2021     1.0        
August 232019 [Member]              
Class of Warrant or Right [Line Items]              
Number of shares of common stock issued   4,475,000          
August 2019 Warrants [Member]              
Class of Warrant or Right [Line Items]              
Warrants exercisable as of June 30, 2021     900,000        
September 2020 Warrants [Member]              
Class of Warrant or Right [Line Items]              
Warrant description On September 4, 2020, the Company entered into a securities purchase agreement with certain institutional investors pursuant to which the Company issued and sold an aggregate of 8,865,000 shares of common stock in a registered direct offering and issued warrants to purchase up to 6,648,750 shares of common stock in a concurrent private placement (the “September 2020 Warrants”). The September 2020 Warrants are initially exercisable for 6,648,750 shares of common stock at an exercise price per share equal to $0.84. The September 2020 Warrants became exercisable beginning on March 9, 2021 and will expire on March 9, 2026.            
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.84       $ 0.84
Date on which warrants became exercisable         Mar. 09, 2021    
Number of warrants exercised     0 4,700,000      
Proceeds from exercise of warrants     $ 0 $ 3,900,000      
August 2019 Warrants [Member]              
Class of Warrant or Right [Line Items]              
Warrant description   On August 23, 2019, the Company entered into a securities purchase agreement with certain institutional investors pursuant to which the Company issued and sold an aggregate of 4,475,000 shares of common stock in a registered direct offering and issued warrants to purchase up to 2,237,500 shares of common stock in a concurrent private placement (the “August 2019 Warrants”). The August 2019 Warrants were initially exercisable for 2,237,500 shares of common stock at an exercise price per share equal to $1.78. The August 2019 Warrants became exercisable beginning on February 27, 2020 and will expire on August 28, 2023.          
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 1.78        
Date on which warrants became exercisable     Feb. 27, 2020        
Number of warrants exercised     0 1,000,000.0      
Proceeds from exercise of warrants     $ 0 $ 1,800,000      
Series A Warrants [Member]              
Class of Warrant or Right [Line Items]              
Warrant description         On January 24, 2019, STI and the Company closed a private placement with certain accredited investors pursuant to which, among other things, the Company issued warrants representing the right to acquire 1,463,519 shares of common stock (the “Series A Warrants”). The Series A Warrants were initially exercisable for 1,463,519 shares of common stock at an exercise price per share equal to $4.15, which was adjusted several times pursuant to the terms thereof to 3,629,023 shares of common stock at an exercise price per share equal to $0.2957 per share. The most recent adjustment to the exercise price (from $0.60 to $0.2957 per share) occurred during the three months ended September 30, 2020 as a result of the announcement of the registered direct offering of 8,865,000 shares of common stock in September 2020. The Series A Warrants were immediately exercisable upon issuance and will expire on January 31, 2024.    
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.2957        
Number of warrants exercised     0 500,000      
Proceeds from exercise of warrants     $ 0 $ 100,000      
Warrants exercisable as of June 30, 2021     300,000